Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker LLYVK
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Sep 2, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 13, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Mar 23, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Mar 23, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 13, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 9, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 6, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 26, 2026 | LLYVK Liberty Live Holdings, Inc. Series C | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 23, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Dec 15, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 8, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 19, 2025 | LLYVK Liberty Live Holdings, Inc. Series C | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances